Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lots of premature talk about loss of the MMP or PDS interest by TPL.

I re-read that in the ComAg a few days ago. That being the case, it really makes me wonder what part of TPL was Leckrone attempting to sell last year? More questions, few answers.

Share
New Message
Please login to post a reply